Immunosurveillance and the evaluation of national immunization programmes: A population-based approach

Epidemiology and Infection

Volumn 121, Issue 3, 1998, Pages 637-643

  De Melker, H E ^a   Conyn Van Spaendonck, M A E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

AGE; ANTIBODY BLOOD LEVEL; ARTICLE; DISEASE TRANSMISSION; HEALTH PROGRAM; HUMAN; IMMUNE STATUS; IMMUNITY; IMMUNIZATION; IMMUNOSURVEILLANCE; INFECTION; MONITORING; NETHERLANDS; QUESTIONNAIRE; RISK; RISK FACTOR; VACCINATION;

BLOOD SPECIMEN COLLECTION; HUMANS; IMMUNIZATION; MONITORING, IMMUNOLOGIC; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032434734     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268898001587     Document Type: Article

References (17)

1. Verbrugge HP. The National Immunisation Programme of the Netherlands. Pediatrics 1990; Suppl: 1060-3.
2. Zwan CW van der, Plantinga AD, Rümke HC, Conynvan Spaendonck MAE. Mazelen in Nederland; epidemiologie en de invloed van vaccinatie. Ned Tijdschr Geneeskd 1994; 138: 2390-5.
3. Visser LG, Rümke HC. De difterie-epidemie in de Russiche Federatie en adviezen ten aanzien van difterie-vaccinatie in Nederland. Ned Tijdschr Geneeskd 1994; 138: 899-901.
4. Huisman J. Difterie: terug van weggeweest? Ned Tijdschr Geneeskd 1994; 138: 892-4.
5. Melker HE, Conyn-van Spaendonck MAE, Rümke HC, Wijngaarden JK van, Mooi FR, Schellekens JFP. Pertussis in the Netherlands: an outbreak despite high levels of immunisation with whole cell vaccine. Emerg Inf Dis 1997; 3: 175-8.
6. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. 2nd ed. New York: Oxford University Press, 1991.
7. Evans AS. Viral infections in humans. Epidemiology and control. 3rd ed. New York and London: Plenum, 1989.
8. Mellinger AK, Cragan JD, Atkinson W, et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 1995; 14: 573-8.
9. Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995; 115: 139-56.
10. Panum P. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Classics 1938-9; 3: 829.
11. Christenson B, Böttiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994; 12: 41-5.
12. Brugha R, Ramsay M, Forsey T, Brown D. A study of maternally derived antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect 1996; 117: 519-24.
13. Fine PEM, Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15: 265-302.
14. Oostvogel PM, Wijngaarden JK van, Avoort HGAM van der et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994; 344: 665-70.
15. Begg N, Miller E. Role of epidemiology in vaccine policy. Vaccine 1990; 8: 180-9.
16. Chen RT, Orenstein WA. Epidemiologic methods in immunization programmes. Epidemiol Rev 1996; 18; 99-117.
17. Evans AS. The need for serologic evaluation of immunisation programmes. Am J Epidemiol 1980; 112: 725-31.